Pharmalot.com, Pharmaceutical Industry News 2013-07-11 In an unusual tactic, an attorney is prodding the FDA to seek documents that purportedly detail side effects caused by
The Philadelphia Inquirer & “Fierce Pharma” 2013-07-10 The U.S. Food and Drug Administration is dragging its feet in addressing concerns that Johnson & Johnson’s antipsychotic
The American Law Journal 2013-06-16 Attorney Stephen Sheller sparred with pharmaceutical defense attorney Hope Freiwald of Dechert law firm on the television program The American
2013-06-25 In a case involving a Philadelphia company, a divided U.S. Supreme Court ruled Monday that federal pharmaceutical laws preempt a person’s ability to sue
2013-05-17 [pdf-embedder url=”http://sheller.com/wp-content/uploads/2013/05/Sheller_PASLRS13_FINAL.pdf”] The law firm of Sheller, P.C. announces the selection of six attorneys as Pennsylvania SuperLawyers® and one as Pennsylvania Rising Star for
2013-02-15 [pdf-embedder url=”http://sheller.com/wp-content/uploads/2015/07/Temple_Times_story_Sheller_Center_for_Social_Justice_2_15_13.pdf”] Featured story: “Sheller Family Foundation’s $1.5 million gift to Temple Law will establish Social Justice Center” Stephen and Sandra Sheller, who
2012-12-31 [pdf-embedder url=”http://sheller.com/wp-content/uploads/2015/07/SH_Forbes_Quote_SAS_12_12.pdf”] A U.S. Appeals Court ruling that pitted free speech rights versus off-label promotion of pharmaceuticals has raised speculation that 2013 may usher
2012-10-05 The first trial in which evidence was taken in the mass tort litigation over Risperdal, the antipsychotic drug that plaintiffs have claimed causes males
2012-10-04 Sheller attorneys announce that five Risperdal cases have been settled for confidential amounts. “Our clients are very pleased,” Steve Sheller, a plaintiffs’ attorney, said
Philadelphia Inquirer 2012-09-28 Public companies file documents with the U.S. Securities and Exchange Commission all the time, and the chief executive officer signs them to
Bloomberg BusinessWeek 2012-09-10 – Johnson & Johnson (JNJ) settled a lawsuit on the first day of a trial over claims its antipsychotic drug Risperdal caused a male
Sheller, P.C.
1515 Market Street, Suite 1100
Philadelphia, PA 19102
Phone: 215-790-7300
info@sheller.com
